Involvement of Norepinephrine in the Control of Activity and Attentive Processes in Animal Models of Attention Deficit Hyperactivity Disorder

Functional and morphological studies in children affected by Attention Deficit Hyperactivity Disorder (ADHD) suggest a prefrontal cortex (PFc) dysfunction. This cortical region is regulated by subcortical systems including noradrenergic (NEergic), dopaminergic (DAergic), cholinergic, serotonergic, and histaminergic pathways. A wealth of data in humans and in animal models demonstrates altered dopamine (DA) regulation. Drugs that modulate norepinephrine (NE) transmission are also effective in ADHD patients, thus leading to the hypothesis of a NEergic disorder. This review covers the regulation of PFc functions by NE and the interaction between the NE and DA systems, as suggested by pharmacological, electrophysiological, morphological, and gene knock out (KO) studies. A negative feedback between NE and DA neurons emerges from KO studies because KO mice showing increased (NE transporter (NET) KO) or decreased (DBH and VMAT2 KO) NE levels are respectively associated with lower and higher DA levels. Locomotor activity can be generally predicted by the DA level, whereas sensitivity to amphetamines is by NE/DA balance. Some animal models of ADHD, such as spontaneously hypertensive rats (SHR), show alterations in the PFc and in the DA system. Evidence about a correlation between the NE system and hyper-locomotion activity in such animals has not yet been clarified. Therefore, this review also includes recent evidence on the behavioral effects of two NET blockers, reboxetine and atomoxetine, in two animal models of ADHD: SHR and Naples High Excitability rats. As these drugs modulate the DA level in the PFc, certain effects are likely to be due to a rebalanced DA system. We discuss the significance of the results for theories of ADHD and make suggestions for future experimentation.

[1]  Susan G. Amara,et al.  Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor , 2000, Biological Psychiatry.

[2]  J. Rapoport,et al.  Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. , 1996, Archives of general psychiatry.

[3]  R. Palmiter,et al.  Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic , 1995, Cell.

[4]  K. Lynch,et al.  Localization ofα2c-adrenergic receptor immunoreactivity in catecholaminergic neurons in the rat central nervous system , 1998, Neuroscience.

[5]  D. Barlow,et al.  Impaired Activity of the Extraneuronal Monoamine Transporter System Known as Uptake-2 inOrct3/Slc22a3-Deficient Mice , 2001, Molecular and Cellular Biology.

[6]  M. Pignatelli,et al.  Prenatal elevation of endocannabinois corrects the unbalance between dopamine systems and reduces activity in the Naples High Excitability rats , 2003, Neuroscience & Biobehavioral Reviews.

[7]  Stewart H Mostofsky,et al.  Smaller prefrontal and premotor volumes in boys with attention-deficit/hyperactivity disorder , 2002, Biological Psychiatry.

[8]  D. Vallone,et al.  The Naples High- and Low-Excitability Rats: Selective Breeding, Behavioral Profile, Morphometry, and Molecular Biology of the Mesocortical Dopamine System , 2002, Behavior genetics.

[9]  T. Svensson,et al.  Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex. , 2001, The Journal of pharmacology and experimental therapeutics.

[10]  G. Chiara,et al.  Blockade of the Noradrenaline Carrier Increases Extracellular Dopamine Concentrations in the Prefrontal Cortex: Evidence that Dopamine Is Taken up In Vivo by Noradrenergic Terminals , 1990, Journal of neurochemistry.

[11]  F. Schenk,et al.  A Behavioral Study of Alpha-1b Adrenergic Receptor Knockout Mice: Increased Reaction to Novelty and Selectively Reduced Learning Capacities , 2001, Neurobiology of Learning and Memory.

[12]  V. Russell,et al.  Increased noradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder — the spontaneously hypertensive rat , 2000, Behavioural Brain Research.

[13]  B. Westerink,et al.  The noradrenaline-dopamine interaction in the rat medial prefrontal cortex studied by multi-probe microdialysis. , 2001, European journal of pharmacology.

[14]  B. Shaywitz,et al.  Differential effects of selective dopamine, norepinephrine or catecholamine depletion on activity and learning in the developing rat , 1983, Pharmacology Biochemistry and Behavior.

[15]  G. Tsujimoto,et al.  Transgenic studies of alpha(1)-adrenergic receptor subtype function. , 2002, Life sciences.

[16]  R. Barkley.  A review of stimulant drug research with hyperactive children. , 1977, Journal of child psychology and psychiatry, and allied disciplines.

[17]  J. Oostendorp,et al.  Contribution of β‐adrenoceptor subtypes to relaxation of colon and oesophagus and pacemaker activity of ureter in wildtype and β3‐adrenoceptor knockout mice , 2000 .

[18]  M. Scheinin,et al.  Behavioral and neurochemical characterization of α2A-adrenergic receptor knockout mice , 2002, Neuroscience.

[19]  S. Faraone,et al.  Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. , 1998, The American journal of psychiatry.

[20]  L. Swanson,et al.  The projections of the ventral tegmental area and adjacent regions: A combined fluorescent retrograde tracer and immunofluorescence study in the rat , 1982, Brain Research Bulletin.

[21]  Kazuto Kobayashi,et al.  Targeted Disruption of the Tyrosine Hydroxylase Locus Results in Severe Catecholamine Depletion and Perinatal Lethality in Mice (*) , 1995, The Journal of Biological Chemistry.

[22]  W Melega,et al.  Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[23]  M. Kano,et al.  Modest Neuropsychological Deficits Caused by Reduced Noradrenaline Metabolism in Mice Heterozygous for a Mutated Tyrosine Hydroxylase Gene , 2000, The Journal of Neuroscience.

[24]  I. Lucki,et al.  Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs. , 2001, The Journal of pharmacology and experimental therapeutics.

[25]  J. Giraldo,et al.  Enhanced noradrenergic transmission in the spontaneously hypertensive rat anococcygeus muscle , 2003, British journal of pharmacology.

[26]  P. Gaspar,et al.  Plasma Membrane Transporters of Serotonin, Dopamine, and Norepinephrine Mediate Serotonin Accumulation in Atypical Locations in the Developing Brain of Monoamine Oxidase A Knock-Outs , 1998, The Journal of Neuroscience.

[27]  P. Goldman-Rakic.  Regional and cellular fractionation of working memory. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Scheinin,et al.  Behavioral and neurochemical characterization of alpha(2A)-adrenergic receptor knockout mice. , 2002, Neuroscience.

[29]  H. Geurts,et al.  The top and the bottom of ADHD: a neuropsychological perspective , 2003, Neuroscience & Biobehavioral Reviews.

[30]  F. Castellanos,et al.  Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes , 2002, Nature Reviews Neuroscience.

[31]  J. Rawlins,et al.  Effects of medial prefrontal cortex cytotoxic lesions in mice , 2003, Behavioural Brain Research.

[32]  E. Bullmore,et al.  Functional frontalisation with age: mapping neurodevelopmental trajectories with fMRI , 2000, Neuroscience & Biobehavioral Reviews.

[33]  S. Sara,et al.  Locus coeruleus activation modulates firing rate and temporal organization of odour‐induced single‐cell responses in rat piriform cortex , 2002, The European journal of neuroscience.

[34]  L. Vanderschuren,et al.  Opposing Role of Dopamine D1 and D2 Receptors in Modulation of Rat Nucleus Accumbens Noradrenaline Release , 1999, The Journal of Neuroscience.

[35]  K. Fuxe,et al.  EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS. , 1964, Acta physiologica Scandinavica. Supplementum.

[36]  K. Hellstrand,et al.  Locomotor activity and catecholamine receptor binding in adult normotensive and spontaneously hypertensive rats , 2005, Journal of Neural Transmission.

[37]  M. Scheinin,et al.  Genetic alteration of the α2-adrenoceptor subtype c in mice affects the development of behavioral despair and stress-induced increases in plasma corticosterone levels , 1999, Molecular Psychiatry.

[38]  Joseph Biederman,et al.  Attention-deficit/hyperactivity disorder (adhd) as a noradrenergic disorder , 1999, Biological Psychiatry.

[39]  D. Segal,et al.  Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine. , 2001, The Journal of pharmacology and experimental therapeutics.

[40]  M. P. McDonald,et al.  The α2A-Adrenergic Receptor Plays a Protective Role in Mouse Behavioral Models of Depression and Anxiety , 2001, The Journal of Neuroscience.

[41]  G. Tsujimoto,et al.  Transgenic studies of α1-adrenergic receptor subtype function , 2002 .

[42]  D. Pfaff,et al.  Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[43]  A. Rashidy-pour,et al.  Reversible lesion of the rat’s orbitofrontal cortex interferes with hippocampus-dependent spatial memory , 2004, Behavioural Brain Research.

[44]  D. Viggiano,et al.  A morphometric evidence for a hyperfunctioning mesolimbic system in an animal model of ADHD , 2002, Behavioural Brain Research.

[45]  T. Robbins.  Arousal systems and attentional processes , 1997, Biological Psychology.

[46]  M. Hirsch,et al.  Control of noradrenergic differentiation and Phox2a expression by MASH1 in the central and peripheral nervous system. , 1998, Development.

[47]  V. Brown,et al.  Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat , 2003, Behavioural Brain Research.

[48]  D. Newman,et al.  Nuclear terminations of corticoreticular fiber systems in rats , 1989 .

[49]  D. Vallone,et al.  Behavioural, pharmacological, morpho-functional molecular studies reveal a hyperfunctioning mesocortical dopamine system in an animal model of attention deficit and hyperactivity disorder , 2003, Neuroscience & Biobehavioral Reviews.

[50]  K. Lynch,et al.  Localization of alpha2C-adrenergic receptor immunoreactivity in catecholaminergic neurons in the rat central nervous system. , 1998, Neuroscience.

[51]  R. Palmiter,et al.  Disruption of the dopamine beta-hydroxylase gene in mice suggests roles for norepinephrine in motor function, learning, and memory. , 1997, Behavioral neuroscience.

[52]  T. Nagatsu,et al.  Functional and high level expression of human dopamine beta-hydroxylase in transgenic mice. , 1994, The Journal of biological chemistry.

[53]  Takeshi Kumazawa,et al.  Increased stress response and β–phenylethylamine in MAOB–deficient mice , 1997, Nature Genetics.

[54]  R. Palmiter,et al.  Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Jonathan Williams,et al.  Dopamine Appetite and Cognitive Impairment in Attention Deficit/Hyperactivity Disorder , 2004, Neural plasticity.

[56]  Cyriel M. A. Pennartz,et al.  Learning-related changes in response patterns of prefrontal neurons during instrumental conditioning , 2003, Behavioural Brain Research.

[57]  G. Hynd,et al.  Brain morphology in developmental dyslexia and attention deficit disorder/hyperactivity. , 1990, Archives of neurology.

[58]  J. Sirviö,et al.  Alpha2-adrenergic control of dopamine overflow and metabolism in mouse striatum. , 1997, European journal of pharmacology.

[59]  Jia-Yi Li,et al.  Enhanced Neuropeptide Y Immunoreactivity and Vasoconstriction in Mesenteric Small Arteries from Spontaneously Hypertensive Rats , 2003, Journal of Vascular Research.

[60]  Davide Viggiano,et al.  Dysfunctions in Dopamine Systems and ADHD: Evidence From Animals and Modeling , 2004, Neural plasticity.

[61]  Fei Xu,et al.  Mice lacking the norepinephrine transporter are supersensitive to psychostimulants , 2000, Nature Neuroscience.

[62]  F. Bloom,et al.  Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle , 1981, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[63]  C. Ferris,et al.  Early androgen treatment decreases cognitive function and catecholamine innervation in an animal model of ADHD , 2000, Behavioural Brain Research.

[64]  H Ujike,et al.  VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[65]  M. P. McDonald,et al.  The alpha(2a)-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety. , 2001, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[66]  Kamala D. Murugaiah,et al.  Beta adrenergic receptors facilitate norepinephrine release from rat hypothalamic and hippocampal slices. , 1995, Research communications in molecular pathology and pharmacology.

[67]  A. Deutch,et al.  Anatomical substrates of orexin–dopamine interactions: lateral hypothalamic projections to the ventral tegmental area , 2002, Neuroscience.

[68]  I. Gritti,et al.  GABAergic and other noncholinergic basal forebrain neurons, together with cholinergic neurons, project to the mesocortex and isocortex in the rat , 1997, The Journal of comparative neurology.

[69]  R. D. Hunt,et al.  An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.

[70]  D. Newman,et al.  Nuclear terminations of corticoreticular fiber systems in rats. , 1989, Brain, behavior and evolution.

[71]  A. Barbelivien,et al.  Metabolic alterations in the prefrontal and cingulate cortices are related to behavioral deficits in a rodent model of attention-deficit hyperactivity disorder. , 2001, Cerebral cortex.

[72]  A. Sadile.  Long-Term Habituation of θ-Related Activity Components of Albino Rats in the Làt-Maze , 1996 .

[73]  V. Brown,et al.  Rodent models of prefrontal cortical function , 2002, Trends in Neurosciences.

[74]  M. Davies,et al.  Augmentation of the noradrenergic system in alpha-2 adrenergic receptor deficient mice: anatomical changes associated with enhanced fear memory , 2003, Brain Research.

[75]  R. Palmiter,et al.  Restoration of Norepinephrine and Reversal of Phenotypes in Mice Lacking Dopamine β‐Hydroxylase , 1998, Journal of neurochemistry.

[76]  K. Berecek,et al.  Reduced activity of locus coeruleus neurons in hypertensive rats , 1985, Neuroscience Letters.

[77]  K. Perry,et al.  Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat: A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder , 2002, Neuropsychopharmacology.

[78]  Nicole C. Rust,et al.  Norepinephrine-Deficient Mice Have Increased Susceptibility to Seizure-Inducing Stimuli , 1999, The Journal of Neuroscience.

[79]  V. Luca,et al.  Cortical spreading depression blocks the hyperthermic reaction induced by orexin a , 2004, Neuroscience.

[80]  A. Goodchild,et al.  Tyrosine hydroxylase gene expression in ventrolateral medulla oblongata of WKY and SHR: a quantitative real-time polymerase chain reaction study , 2002, Autonomic Neuroscience.

[81]  A. Correspondent,et al.  Genetic manipulation , 1974, Nature.

[82]  J. O'Donnell.  Effect of the beta-2 adrenergic agonist zinterol on norepinephrine turnover. , 1993, Research communications in chemical pathology and pharmacology.

[83]  Joaquín M. Fuster,et al.  Executive frontal functions , 2000, Experimental Brain Research.

[84]  James H. Fallon,et al.  Locus coeruleus projections to cortex: Topography, morphology and collateralization , 1982, Brain Research Bulletin.

[85]  C. Saper,et al.  Colocalization of orexin a and glutamate immunoreactivity in axon terminals in the tuberomammillary nucleus in rats , 2003, Neuroscience.

[86]  A. Ferron,et al.  Electrophysiological effects of methylphenidate on the coeruleo-cortical noradrenergic system in the rat. , 1988, European journal of pharmacology.

[87]  X. Morin,et al.  Defects in Sensory and Autonomic Ganglia and Absence of Locus Coeruleus in Mice Deficient for the Homeobox Gene Phox2a , 1997, Neuron.

[88]  S. Foote,et al.  Locus coeruleus electrophysiological activity and responsivity to corticotropin-releasing factor in inbred hypertensive and normotensive rats , 1997, Brain Research.

[89]  D. Greco,et al.  Altered midbrain dopaminergic neurotransmission during development in an animal model of ADHD , 2003, Neuroscience & Biobehavioral Reviews.

[90]  T. Kumai,et al.  Elevated tyrosine hydroxylase mRNA levels in medulla oblongata of spontaneously hypertensive rats. , 1996, Brain research. Molecular brain research.

[91]  A. Arnsten,et al.  Catecholamine regulation of the prefrontal cortex , 1997, Journal of psychopharmacology.

[92]  J. Glowinski,et al.  α1b-Adrenergic Receptors Control Locomotor and Rewarding Effects of Psychostimulants and Opiates , 2002, The Journal of Neuroscience.

[93]  F. Nicoletti,et al.  Alpha‐1B adrenergic receptor knockout mice are protected against methamphetamine toxicity , 2003, Journal of neurochemistry.

[94]  Y. Kitaoka,et al.  Biochemical and morphological characterization of spontaneously hypertensive hyperlipidaemic rats , 2003, Clinical and experimental pharmacology & physiology.

[95]  G. Chiara,et al.  Effect of amphetamine, cocaine and depolarization by high potassium on extracellular dopamine in the nucleus accumbens shell of SHR rats. An in vivo microdyalisis study , 2003, Neuroscience & Biobehavioral Reviews.

[96]  M. Reith,et al.  Extracellular dopamine, norepinephrine, and serotonin in the ventral tegmental area and nucleus accumbens of freely moving rats during intracerebral dialysis following systemic administration of cocaine and other uptake blockers , 1997, Psychopharmacology.

[97]  F. Bloom,et al.  Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. , 1983, Physiological reviews.

[98]  Robert P. Carson,et al.  Genetic manipulation of noradrenergic neurons. , 2002, The Journal of pharmacology and experimental therapeutics.

[99]  T. Robbins,et al.  Dissociable aspects of performance on the 5-choice serial reaction time task following lesions of the dorsal anterior cingulate, infralimbic and orbitofrontal cortex in the rat: differential effects on selectivity, impulsivity and compulsivity , 2003, Behavioural Brain Research.

[100]  M. Goris,et al.  Interhemispheric asymmetry of regional cerebral blood flow in prepubescent boys with attention deficit hyperactivity disorder , 2001, Nuclear medicine communications.

[101]  G. Aston-Jones,et al.  Potent excitatory influence of prefrontal cortex activity on noradrenergic locus coeruleus neurons , 1998, Neuroscience.

[102]  B. Bunney,et al.  Dual Effects of d-Amphetamine on Dopamine Neurons Mediated by Dopamine and Nondopamine Receptors , 2000, The Journal of Neuroscience.

[103]  R. Palmiter,et al.  Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development , 1995, Nature.

[104]  L. Philip,et al.  Extracellular catechol and indole turnover in the nucleus of the solitary tract of spontaneously hypertensive and Wistar-Kyoto normotensive rats in response to drug-induced changes in arterial blood pressure , 1996, Brain Research Bulletin.

[105]  D. Viggiano,et al.  Hypertrophic A10 dopamine neurones in a rat model of attention‐deficit hyperactivity disorder (ADHD) , 2000, Neuroreport.

[106]  J. Shih,et al.  Increased stress response and beta-phenylethylamine in MAOB-deficient mice. , 1997, Nature genetics.

[107]  L. Howes,et al.  Age related changes of catecholamines and their metabolites in central nervous system regions of spontaneously hypertensive (SHR) and normotensive Wistar-Kyoto (WKY) rats. , 1984, Clinical and experimental hypertension. Part A, Theory and practice.

[108]  J. Tanaka,et al.  Decreased monoamine release in the median preoptic area following ventricular treatment with the angiotensin II antagonist saralasin in normotensive and spontaneously hypertensive rats , 2002, Regulatory Peptides.

[109]  O. Phillipson.  Afferent projections to the ventral tegmental area of Tsai and interfascicular nucleus: A horseradish peroxidase study in the rat , 1979, The Journal of comparative neurology.

[110]  H. Rockman,et al.  Beta-adrenergic axis and heart disease. , 2001, Trends in genetics : TIG.

[111]  S. V. Prasad,et al.  β-Adrenergic axis and heart disease , 2001 .

[112]  R. Holman,et al.  A Microdialysis Study of the Regulation of Endogenous Noradrenaline Release in the Rat Hippocampus , 1991, Journal of neurochemistry.

[113]  C. Berridge,et al.  The locus coeruleus–noradrenergic system: modulation of behavioral state and state-dependent cognitive processes , 2003, Brain Research Reviews.

[114]  Menek Goldstein,et al.  Activation of the locus coeruleus induced by selective stimulation of the ventral tegmental area , 1986, Brain Research.

[115]  B. Kolb,et al.  Do rats have a prefrontal cortex? , 2003, Behavioural Brain Research.

[116]  Scott Sands,et al.  Overexpression of the α1B-adrenergic receptor causes apoptotic neurodegeneration: Multiple system atrophy , 2000, Nature Medicine.

[117]  James H. Fallon,et al.  Monoamine innervation of the forebrain: Collateralization , 1982, Brain Research Bulletin.

[118]  A. Sadile,et al.  Behavioral habituation to spatial novelty: Interference and noninterference studies , 1994, Neuroscience & Biobehavioral Reviews.

[119]  α2C-Adrenoceptors modulate the effect of methylphenidate on response rate and discrimination accuracy in an operant test , 2001, Brain Research Bulletin.

[120]  C. Aoki,et al.  Cellular and subcellular sites for noradrenergic action in the monkey dorsolateral prefrontal cortex as revealed by the immunocytochemical localization of noradrenergic receptors and axons. , 1998, Cerebral cortex.

[121]  [Attention deficit hyperactivity disorder. Cerebral asymmetry observed on magnetic resonance]. , 2000, Revista de neurologia.

[122]  J. Glowinski,et al.  d-Amphetamine Fails to Increase Extracellular Dopamine Levels in Mice Lacking α1b-Adrenergic Receptors: Relationship between Functional and Nonfunctional Dopamine Release , 2002, The Journal of Neuroscience.

[123]  E. Sonuga-Barke,et al.  Inhibitory Deficits, Delay Aversion and Preschool AD/HD: Implications for the Dual Pathway Model , 2004, Neural plasticity.

[124]  S. T. Mason,et al.  Noradrenaline in the brain: Progress in theories of behavioural function , 1981, Progress in Neurobiology.

[125]  J. Glowinski,et al.  Importance of the Noradrenaline–Dopamine Coupling in the Locomotor Activating Effects of d-Amphetamine , 1998, The Journal of Neuroscience.

[126]  S. Kaehler,et al.  Release of catecholamines in the locus coeruleus of freely moving and anaesthetized normotensive and spontaneously hypertensive rats: effects of cardiovascular changes and tail pinch , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.